blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0698117

EP0698117 - MONOCLONAL ANTIBODIES AGAINST CK-MB [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  10.10.2003
Database last updated on 15.06.2024
Most recent event   Tooltip17.04.2015Change - lapse in a contracting statepublished on 20.05.2015  [2015/21]
Applicant(s)For all designated states
Roche Diagnostics GmbH
Sandhofer Strasse 116
68305 Mannheim / DE
[N/P]
Former [1999/11]For all designated states
Roche Diagnostics GmbH
68298 Mannheim / DE
Former [1996/09]For all designated states
BOEHRINGER MANNHEIM GMBH
D-68298 Mannheim / DE
Inventor(s)01 / HÜBNER-PARAJSZ, Christa
Marienstrasse 11
D-82327 Tutzing / DE
02 / ESSIG, Ulrich
Josef-von-Hirsch-Strasse 51
D-82152 Planegg / DE
03 / LANG, Fridl
Herzogstandstrasse 2
D-82327 Tutzing / DE
04 / VOGEL, Rudolf
Am Eselsberg 7
D-82362 Weilheim / DE
[1996/09]
Application number, filing date94916161.628.04.1994
[1996/09]
WO1994EP01337
Priority number, dateDE1993431425430.04.1993         Original published format: DE 4314254
[1996/09]
Filing languageDE
Procedural languageDE
PublicationType: A2 Application without search report
No.:WO9425617
Date:10.11.1994
[1994/25]
Type: A1 Application with search report 
No.:EP0698117
Date:28.02.1996
[1996/09]
Type: B1 Patent specification 
No.:EP0698117
Date:04.12.2002
Language:DE
[2002/49]
Search report(s)International search report - published on:EP22.12.1994
ClassificationIPC:C12P21/08, C12N5/00, G01N33/573
[1996/09]
CPC:
C07K16/40 (EP,US); G01N33/573 (EP,US)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   SE [1996/09]
TitleGerman:MONOKLONALE ANTIKÖRPER GEGEN CK-MB[1996/09]
English:MONOCLONAL ANTIBODIES AGAINST CK-MB[1996/09]
French:ANTICORPS MONOCLONAUX CONTRE L'ISOENZYME CK-MB[1996/09]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase30.11.1995National basic fee paid 
30.11.1995Designation fee(s) paid 
30.11.1995Examination fee paid 
Examination procedure09.08.1994Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.11.1995Examination requested  [1996/09]
14.02.2001Despatch of a communication from the examining division (Time limit: M04)
14.03.2001Reply to a communication from the examining division
27.07.2001Despatch of a communication from the examining division (Time limit: M04)
10.08.2001Reply to a communication from the examining division
31.10.2001Despatch of a communication from the examining division (Time limit: M04)
15.11.2001Reply to a communication from the examining division
18.02.2002Despatch of communication of intention to grant (Approval: Yes)
26.06.2002Communication of intention to grant the patent
16.08.2002Fee for grant paid
16.08.2002Fee for publishing/printing paid
Divisional application(s)EP02012972.2  / EP1254913
Opposition(s)05.09.2003No opposition filed within time limit [2003/48]
Fees paidRenewal fee
02.05.1996Renewal fee patent year 03
02.05.1997Renewal fee patent year 04
04.05.1998Renewal fee patent year 05
03.05.1999Renewal fee patent year 06
13.04.2000Renewal fee patent year 07
12.04.2001Renewal fee patent year 08
12.04.2002Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Former [2007/16]LU30.04.2003
Cited inInternational search[A]EP0228174  (UNIV WASHINGTON [US]) [A] 1-21*see the whole application and more particularly , claim 1, page 9, line 26 to page 10, line 15, page 27, lines 7-10. *
 [Y]  - D. WOLFSON ET AL., "Three rapid immunoassays for the detemination of creatine kinase MB", AMERICAN HEART JOURNAL, (199110), vol. 122, no. 4, pages 958 - 964 [Y] 1-21 *see the whole document*
 [Y]  - E. S. LIANIDOU ET AL., "Assay of creatine kinase isoenzyme MB in serum with time-resolved immunofluorometry", CLIN. CHEM., (1990), vol. 36, no. 9, pages 1679 - 1683 [Y] 1-21 *see the whole document*
 [Y]  - U. PIRAN ET AL., "Immunochemiluminometric Assay of creatine kinase MB with a monoclonal antibody to the MB isoenzyme", CLIN. CHEM., (1987), vol. 33, no. 9, pages 1517 - 1520 [Y] 1-21 *see the whole document*
 [Y]  - M. N. BADMINGTON ET AL., "Evaluation of a new rapid immunometric method for the measurement of the MB isoenzyme of creatine kinase in serum", ANN. CLIN. BIOCHEM., (1992), vol. 29, pages 563 - 564 [Y] 1-21 *see the whole document*
 [A]  - H. C. VAIDYA ET AL., "Direct measurement of creatine kinase MB activity in serum after extraction with a monoclonal antibody specific to the MB isoenzyme", CLIN. CHEM., (1986), vol. 32, no. 4, pages 657 - 663 [A] 1-21 *see the whole document*
Examination   - APPLE F, ET AL., "Clinical and analytical evaluation of two immunoassays for direct measurement of creatine kinase MB with two monoclonal anti-CK-MB antibodies.", CLINICAL CHEMISTRY, (1988), vol. 34, no. 11, pages 2364 - 2367
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.